| Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers (NCT05519878) | City of Hope Medical Center | 2022-11-29 |
| Adding Itacitinib to Cyclophosphamide and Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Hematopoietic Stem Cell Transplants (NCT05364762) | City of Hope Medical Center | 2022-11-23 |
| Radioimmunotherapy (111Indium/225Actinium-DOTA-daratumumab) for the Treatment of Relapsed/Refractory Multiple Myeloma (NCT05363111) | City of Hope Medical Center | 2022-11-22 |
| 8-Chloroadenosine in Combination With Venetoclax for the Treatment of Patients With Relapsed/Refractory Acute Myeloid Leukemia (NCT05263284) | City of Hope Medical Center | 2022-10-31 |
| Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma (NCT04930653) | City of Hope Medical Center | 2022-10-19 |
| Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases (NCT05285358) | City of Hope Medical Center | 2022-09-19 |
| Telehealth Exercise Intervention to Improve Cardiovascular Health in Lymphoma Survivors, TECHS Trial (NCT05205512) | City of Hope Medical Center | 2022-09-14 |
| A High Intensity Electronic Health Intervention for the Reduction of Learning Disparities in Childhood Cancer Survivors (NCT05428176) | City of Hope Medical Center | 2022-09-10 |
| Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast Cancer (NCT05340673) | City of Hope Medical Center | 2022-09-09 |
| An Investigational Scan (64Cu-Labeled M5A Antibody) in Combination With SOC Chemotherapy and Radiotherapy in Locally Advanced Rectal Cancer (NCT05245786) | City of Hope Medical Center | 2022-08-31 |
| RefleXion PET/CT Imaging Performance in Patients With Prostate Cancer (NCT05470699) | City of Hope Medical Center | 2022-08-29 |
| iConquerFear Program for the Treatment of Fear of Cancer Recurrence in Patients With Localized Renal Cell Carcinoma (NCT04688333) | City of Hope Medical Center | 2022-08-20 |
| AOH1996 for the Treatment of Refractory Solid Tumors (NCT05227326) | City of Hope Medical Center | 2022-08-12 |
| Feasibility of Cell-Free DNA Liquid Biopsy in Screening High-Risk Patients for Lung Cancer (NCT05384769) | City of Hope Medical Center | 2022-07-29 |
| Navitoclax, Venetoclax, and Decitabine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Previously Treated With Venetoclax (NCT05222984) | City of Hope Medical Center | 2022-07-29 |
| 90Y-DOTA-anti-CD25 Basiliximab, Fludarabine, Melphalan, and Total Marrow and Lymphoid Irradiation for the Treatment of High-Risk Acute Leukemia or Myelodysplastic Syndrome (NCT05139004) | City of Hope Medical Center | 2022-07-19 |
| Occupational Therapy Fatigue Management-Based Intervention for Metastatic Renal Cell Carcinoma (NCT04961320) | City of Hope Medical Center | 2022-07-15 |
| TMLI and Alemtuzumab for Treatment of Sickle Cell Disease (NCT05384756) | City of Hope Medical Center | 2022-07-13 |
| Effects of Ribociclib and Palbociclib on Tumor and Blood Characteristics in Patients With Metastatic Breast Cancer (NCT05244434) | City of Hope Medical Center | 2022-07-03 |
| A Mobile Application, Oncpatient, to Assist Patients Undergoing Radiation Therapy (NCT05173961) | City of Hope Medical Center | 2022-06-29 |
| Copanlisib and Venetoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma (NCT04939272) | City of Hope Medical Center | 2022-06-29 |
| Glasdegib-Based Treatment Combinations for the Treatment of Patients With Relapsed Acute Myeloid Leukemia Who Have Undergone Hematopoietic Cell Transplantation (NCT04655391) | City of Hope Medical Center | 2022-06-25 |
| The Effect of Exercise and Nicotinamide Riboside Muscle Health and Insulin Resistance in Survivors of Childhood Cancer (NCT05023993) | City of Hope Medical Center | 2022-06-23 |
| Reproducibility and Accuracy of a Portable System for Early Detection of Cardiac Dysfunction in Childhood Cancer Survivors (NCT05138991) | City of Hope Medical Center | 2022-06-22 |
| Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR) (NCT05371132) | City of Hope Medical Center | 2022-06-20 |
| An Immunotherapy Vaccine (PIpepTolDC) for the Treatment of Patients With Type 1 Diabetes (NCT04590872) | City of Hope Medical Center | 2022-06-16 |
| Diabetes Prevention Program (METFIT) in Reducing Insulin Resistance in Stage I-III Breast Cancer Survivors (NCT04560439) | City of Hope Medical Center | 2022-06-15 |
| Actinium 225 Labeled Anti-CEA Antibody (Ac225-DOTA-M5A) for the Treatment of CEA Producing Advanced or Metastatic Cancers (NCT05204147) | City of Hope Medical Center | 2022-06-02 |
| Analysis of Whole Body Magnetic Resonance Imaging and Liquid Biopsy for Early Detection of Cancer in Patients With a Strong Family History of Cancer (NCT05868486) | City of Hope Medical Center | 2022-05-20 |
| Radiotherapy in Combination With Atezolizumab in Locally Advanced Borderline Resectable or Unresectable Cutaneous SCC (NCT05085496) | City of Hope Medical Center | 2022-04-19 |
| 64Cu-DOTA-pembrolizumab PET for the Study of PD1 Expression (NCT04605614) | City of Hope Medical Center | 2022-04-15 |
| Low Dose Versus Standard Dose Dexamethasone for Reduction of Swelling in Patients with Primary or Metastatic Brain Tumors (NCT05139043) | City of Hope Medical Center | 2022-04-09 |
| Circulating Biomarkers in the Development of Type 1 Diabetes (NCT05505669) | City of Hope Medical Center | 2022-03-29 |
| Venetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell Acute Lymphoblastic Leukemia (NCT05157971) | City of Hope Medical Center | 2022-03-17 |
| Minnelide and Osimertinib for the Treatment of Advanced EGFR Mutated Non-Small Cell Lung Cancer (NCT05166616) | City of Hope Medical Center | 2022-03-07 |
| Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma in African-American and European-American Patients (NCT05014646) | City of Hope Medical Center | 2022-03-07 |
| TBI Using IMRT and Cyclophosphamide Prior to Stem Cell Transplant for the Treatment of Severe Systemic Sclerosis (NCT04380831) | City of Hope Medical Center | 2022-02-24 |
| Chemoradiation and Pembrolizumab Followed by Pembrolizumab and Lenvatinib Before Surgery for the Treatment of Non-metastatic Esophageal or Esophageal/Gastroesophageal Junction Cancer (NCT04929392) | City of Hope Medical Center | 2022-01-25 |
| CC-486 and Nivolumab for the Treatment of Hodgkin Lymphoma Refractory to PD-1 Therapy or Relapsed (NCT05162976) | City of Hope Medical Center | 2022-01-03 |
| HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics (NCT04905082) | City of Hope Medical Center | 2021-12-30 |
| Brentuximab Vedotin and Nivolumab for the Treatment of Patients With Relapsed/Refractory Classical Hodgkin Lymphoma (NCT04561206) | City of Hope Medical Center | 2021-11-12 |
| 64 Cu-DOTA-alendronate PET Imaging in Localizing and Characterizing Breast Calcifications in Participants Before Undergoing Mastectomy (NCT03542695) | City of Hope Medical Center | 2021-11-03 |
| Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma (NCT04871607) | City of Hope Medical Center | 2021-11-02 |
| CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cancer (NCT05122546) | City of Hope Medical Center | 2021-11-01 |
| Perception of Cure Among Patients With Metastatic Cancer (NCT04820894) | City of Hope Medical Center | 2021-10-30 |
| Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules (NCT05229341) | City of Hope Medical Center | 2021-10-22 |
| Perioperative Telemonitoring to Optimize Cancer Care and Outcomes (NCT04986566) | City of Hope Medical Center | 2021-10-19 |
| CF33-hNIS-antiPDL1 for the Treatment of Metastatic Triple Negative Breast Cancer (NCT05081492) | City of Hope Medical Center | 2021-10-18 |
| Telehealth Exercise Intervention to Improve Physical Function and Frailty in Multiple Myeloma Survivors (NCT05142371) | City of Hope Medical Center | 2021-10-06 |
| Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer (NCT04158635) | City of Hope Medical Center | 2021-09-01 |
| App-Based Mindfulness Intervention for the Improvement of Quality of Life in Patients With Metastatic Renal Cell Cancer (NCT04788095) | City of Hope Medical Center | 2021-08-23 |
| Durvalumab and Tremelimumab After Radioembolization for the Treatment of Unresectable, Locally Advanced Liver Cancer (NCT04605731) | City of Hope Medical Center | 2021-08-03 |
| Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast Cancer (NCT04913064) | City of Hope Medical Center | 2021-07-27 |
| CpG-STAT3 siRNA CAS3/SS3 and Localized Radiation Therapy for the Treatment of Relapsed/Refractory B-Cell NHL (NCT04995536) | City of Hope Medical Center | 2021-07-27 |
| Cancer Pain Rehabilitation Program to Reduce Pain Related Distress, and Reliance of Pain Medication Through Multimodal Nonpharmacological Solutions (NCT05036408) | City of Hope Medical Center | 2021-07-21 |
| Lenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancreatic Cancer (NCT04887805) | City of Hope Medical Center | 2021-07-21 |
| Telehealth Exercise Platform to Reduce Frailty After Bone Marrow Transplant (NCT04968119) | City of Hope Medical Center | 2021-07-12 |
| Lung Cancer Risk Assessment and Etiology (NCT06328621) | City of Hope Medical Center | 2021-07-02 |
| A Multidisciplinary Approach to Improve the Health of Older Adults With Blood Cancers After Stem Cell Transplantation (NCT04914338) | City of Hope Medical Center | 2021-06-03 |
| LB-100, Carboplatin, Etoposide, and Atezolizumab for the Treatment of Untreated Extensive-Stage Small Cell Lung Cancer (NCT04560972) | City of Hope Medical Center | 2021-05-28 |
| Physical Activity Intervention Before and After Surgery in Older Adults With Lung Cancer and Their Family Caregivers (NCT04085081) | City of Hope Medical Center | 2021-05-15 |
| White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CA (NCT04519879) | City of Hope Medical Center | 2021-05-10 |
| Leflunomide for the Treatment of Relapsed or Refractory CD30+ Lymphoproliferative Disorders (NCT04463615) | City of Hope Medical Center | 2021-05-05 |
| Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer (NCT04734730) | City of Hope Medical Center | 2021-05-04 |
| Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant (NCT04177004) | City of Hope Medical Center | 2021-04-30 |
| Study to Detect Changes in Urinary and Gut Microbiome During Androgen Deprivation Therapy and Radiation Therapy in Patients With Prostate Cancer (NCT04775355) | City of Hope Medical Center | 2021-04-14 |
| Acalabrutinib, Umbralisib, and Ublituximab for the Treatment of Previously Untreated Mantle Cell Lymphoma (NCT04783415) | City of Hope Medical Center | 2021-03-26 |
| Acalabrutinib for the Treatment of Relapsed or Refractory Autoimmune Hemolytic Anemia in Patients With Chronic Lymphocytic Leukemia (NCT04657094) | City of Hope Medical Center | 2021-03-16 |
| Microbial Diversity Between Inflamed and Non-inflamed Skin of Patients With Immune Checkpoint Inhibitor-Induced Dermatitis (NCT04812197) | City of Hope Medical Center | 2021-03-08 |
| A Nurse-Led Intervention for Fear of Progression in Advanced Cancer (NCT04819997) | City of Hope Medical Center | 2021-03-08 |
| Brain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or Medulloblastoma (NCT04661384) | City of Hope Medical Center | 2021-03-05 |
| Home Base Telemonitoring in Gastrointestinal, Genitourinary, or Gynecologic Cancer Patients Undergoing Abdominal Surgery (NCT04596384) | City of Hope Medical Center | 2021-02-16 |
| Polatuzumab Vedotin, Rituximab, Ifosfamide, Carboplatin, and Etoposide (PolaR-ICE) as Initial Salvage Therapy for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (NCT04665765) | City of Hope Medical Center | 2021-01-18 |
| Leflunomide for the Treatment of Severe COVID-19 in Patients With a Concurrent Malignancy (NCT04532372) | City of Hope Medical Center | 2021-01-07 |
| Modified Immune Cells (CD19 CAR T Cells) and Acalabrutinib for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma (NCT04484012) | City of Hope Medical Center | 2020-12-31 |
| CAR T Cells After Lymphodepletion for the Treatment of IL13Rα2 Positive Recurrent or Refractory Brain Tumors in Children (NCT04510051) | City of Hope Medical Center | 2020-12-04 |
| Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma (NCT04508790) | City of Hope Medical Center | 2020-11-24 |
| Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies (NCT04681105) | City of Hope Medical Center | 2020-11-18 |
| Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST Study (NCT04537871) | City of Hope Medical Center | 2020-11-18 |
| Itacitinib, Tacrolimus, and Sirolimus for the Prevention of GVHD in Patients With Acute Leukemia, Myelodysplastic Syndrome, or Myelofibrosis Undergoing Reduced Intensity Conditioning Donor Stem Cell Transplantation (NCT04339101) | City of Hope Medical Center | 2020-11-11 |
| Technology-Enabled Activation of Skin Cancer Screening for Stem Cell Transplant Survivors and Their Primary Care Providers, TEACH Study (NCT04358276) | City of Hope Medical Center | 2020-10-30 |
| Flotetuzumab in Treating Patients With Recurrent or Refractory CD123 Positive Blood Cancer (NCT03739606) | City of Hope Medical Center | 2020-10-20 |
| Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma (NCT04370483) | City of Hope Medical Center | 2020-10-08 |
| Researching the Effect of Exercise on Cancer (NCT04589468) | City of Hope Medical Center | 2020-10-02 |
| SARS-CoV-2 Donor-Recipient Immunity Transfer (NCT04666025) | City of Hope Medical Center | 2020-09-23 |
| Dabrafenib, Trametinib, and IMRT in Treating Patients With BRAF Mutated Anaplastic Thyroid Cancer (NCT03975231) | City of Hope Medical Center | 2020-09-14 |
| PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer (NCT04329494) | City of Hope Medical Center | 2020-08-21 |
| Family Caregivers in Underserved Populations Providing Complex Cancer Care (NCT05213078) | City of Hope Medical Center | 2020-07-15 |
| An Imaging Agent (I-124 M5A) in Detecting CEA-Positive Liver Metastases in Patients With Colorectal Cancer (NCT03993327) | City of Hope Medical Center | 2020-07-15 |
| Analysis of Coronavirus Disease 19 (COVID-19) Convalescent Plasma (NCT04497779) | City of Hope Medical Center | 2020-07-13 |
| Self-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal Cancer (NCT04428905) | City of Hope Medical Center | 2020-07-11 |
| Yttrium Y 90 Basiliximab and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Mature T-cell Non-Hodgkin Lymphoma (NCT02342782) | City of Hope Medical Center | 2020-06-08 |
| Regorafenib, Ipilimumab and Nivolumab for the Treatment of Chemotherapy Resistant Microsatellite Stable Metastatic Colorectal Cancer (NCT04362839) | City of Hope Medical Center | 2020-05-27 |
| Intermittent Duvelisib Dosing in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT03961672) | City of Hope Medical Center | 2020-05-13 |
| Leflunomide in Treating Patients With Steroid Dependent Chronic Graft Versus Host Disease (NCT04212416) | City of Hope Medical Center | 2020-05-12 |
| Pembrolizumab and Decitabine With or Without Venetoclax in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome That Is Newly-Diagnosed, Recurrent, or Refractory (NCT03969446) | City of Hope Medical Center | 2020-05-04 |
| Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer. (NCT04305834) | City of Hope Medical Center | 2020-03-25 |
| Early Detection of Advanced Adenomas and Colorectal Cancer (NCT06342440) | City of Hope Medical Center | 2020-03-15 |
| Brigatinib and Bevacizumab for the Treatment of ALK-Rearranged Locally Advanced, Metastatic, or Recurrent NSCLC (NCT04227028) | City of Hope Medical Center | 2020-03-09 |
| TBI Using IMRT (VMAT or Tomotherapy) for the Prevention of Pul Toxicities in Patients Undergoing Donor SCT (NCT04281199) | City of Hope Medical Center | 2020-02-28 |